NVS stock Statistics — Novartis AG filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2025-12-31 · filed common shares: 1.90B
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.29%
Short ratioDays to cover, as published by FINRA: 4.22
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 35.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 32.70%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Sign in

Avg volume (3 months)

Gross marginFY Dec 25: 78.81%
Operating marginFY Dec 25: 32.36%
Net margin: —
EBITDA marginFY Dec 25: 34.61%
Return on equityNet income (FY Dec 25) ÷ average shareholders equity: 31.01%
Return on assetsNet income (FY Dec 25) ÷ average total assets: 13.12%

Cash & equivalentsas of Dec 25: $11.43B
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 25: $30.64B
Debt / equityas of Dec 25: 66.44%
Current ratioas of Dec 25: 1.12
Quick ratio: —
Operating cash flowFY Dec 25: $19.14B
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 25: $17.59B
TTM revenue / diluted shareDiluted, FY Dec 25: 27.89